Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Edwards Lifesciences Corp (EW)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,420,948
  • Shares Outstanding, K 211,620
  • Annual Sales, $ 2,964 M
  • Annual Income, $ 569,500 K
  • 36-Month Beta 0.51
  • Price/Sales 8.25
  • Price/Cash Flow 36.51
  • Price/Book 7.91

Price Performance

See More
Period Period Low Period High Performance
1-Month
104.12 +10.83%
on 11/14/17
119.04 -3.06%
on 11/30/17
+10.16 (+9.65%)
since 11/13/17
3-Month
100.20 +15.17%
on 10/30/17
119.04 -3.06%
on 11/30/17
+3.62 (+3.24%)
since 09/13/17
52-Week
86.55 +33.33%
on 02/02/17
121.45 -4.98%
on 07/27/17
+26.03 (+29.13%)
since 12/13/16

Most Recent Stories

More News
Sage Therapeutics, Dollar General jump; LendingClub tumbles

NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday:

EW : 115.40 (-0.15%)
SAGE : 164.65 (+2.62%)
TLRD : 20.46 (+5.14%)
Edwards Lifesciences Buys Harpoon Medical, Expands Portfolio

Edwards Lifesciences (EW) expands Surgical Heart Valve Therapy segment with the buyout of Harpoon Medical.

PETS : 45.05 (+3.54%)
EW : 115.40 (-0.15%)
MYGN : 33.27 (+2.12%)
ALGN : 235.63 (+0.54%)
Edwards Lifesciences' Board Approves New $1 Billion Share Repurchase Program

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced today that its Board of Directors recently...

EW : 115.40 (-0.15%)
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will discuss the company's strategy for longer-term...

EW : 115.40 (-0.15%)
Edwards Acquires Harpoon Medical

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced the acquisition of Harpoon Medical,...

EW : 115.40 (-0.15%)
Implied Volatility Surging for Edwards Lifesciences (EW) Stock Options

Edwards Lifesciences (EW) needs investors to pay close attention to the stock based on moves in the options market lately.

EW : 115.40 (-0.15%)
Edwards Lifesciences' Pipeline Strong Amid Rising Expenses

Edwards Lifesciences' (EW) aim at building its pipeline to fortify foothold across all operating businesses augurs well for the company. However, higher operating expenses are a concern.

PETS : 45.05 (+3.54%)
EW : 115.40 (-0.15%)
MYGN : 33.27 (+2.12%)
LMNX : 20.52 (+0.64%)
BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology...

EW : 115.40 (-0.15%)
BSGM : 1.3500 (-0.74%)
Analysis: Positioning to Benefit within Oclaro, SLM, Regency Centers, Celanese, Ameriprise, and Edwards Lifesciences - Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Oclaro, Inc. (NASDAQ:OCLR),...

CE : 108.31 (+1.25%)
EW : 115.40 (-0.15%)
AMP : 166.42 (-1.29%)
SLM : 11.16 (-3.88%)
REG : 68.76 (+0.25%)
OCLR : 7.50 (+6.08%)
Edwards SAPIEN 3 Transcatheter Valve Demonstrates Significant Cost Savings Over Surgery In Intermediate Risk Patients

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced new data demonstrating substantial...

EW : 115.40 (-0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More

Business Summary

Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards...

See More

Key Turning Points

2nd Resistance Point 116.98
1st Resistance Point 116.19
Last Price 115.40
1st Support Level 114.96
2nd Support Level 114.52

See More

52-Week High 121.45
Last Price 115.40
Fibonacci 61.8% 108.12
Fibonacci 50% 104.00
Fibonacci 38.2% 99.88
52-Week Low 86.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.